Afstyla® (antihemophilic factor (Recombinant), single chain lyophilized powder)
for Hemophilia

Afstyla is a recombinant, single-chain antihemophilic factor used to control and prevent bleeding episodes in people with hemophilia A. It is also administered before surgery to prevent excessive bleeding. Afstyla replaces the missing clotting factor VIII in the blood, helping to restore normal clotting function and reduce the risk of prolonged or internal bleeding, particularly in the joints and muscles.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Hemophilia